Imagin Medical Inc. | Income Statement

Fiscal year is October-September. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
4.50
12.20
-
14.50
14.20
14
Gross Income
4.50
12.20
-
14.50
14.20
14
SG&A Expense
555.30
556.10
57.50
2,240.80
1,515.90
7,938.20
EBIT
559.80
568.40
-
2,255.40
1,530.10
7,952.20
Unusual Expense
45.30
1,452.90
-
0.00
-
-
Non Operating Income/Expense
6.20
0.10
0.60
3.00
4.60
15.90
Interest Expense
-
0.90
0.10
1.30
7.40
9.20
Pretax Income
493.40
2,014.40
58.20
2,259.60
1,542.10
7,958.10
Consolidated Net Income
493.40
2,014.40
58.20
2,259.60
1,542.10
7,958.10
Net Income
493.40
2,014.40
58.20
2,259.60
1,542.10
7,958.10
Net Income After Extraordinaries
493.40
2,014.40
58.20
2,259.60
1,542.10
7,958.10
Net Income Available to Common
493.40
2,014.40
58.20
2,259.60
1,542.10
7,958.10
EPS (Basic)
0.15
0.51
0.06
0.08
0.03
0.07
Basic Shares Outstanding
3,881.40
3,888.60
897.60
26,873.50
49,089.20
107,379.40
EPS (Diluted)
0.13
0.52
0.06
0.08
0.03
0.07
Diluted Shares Outstanding
3,881.40
3,888.60
897.60
26,873.50
49,089.20
107,379.40
EBITDA
555.30
556.10
57.50
2,240.80
1,515.90
7,938.20
Non-Operating Interest Income
14.90
8.00
-
0.10
0.00
19.30

About Imagin Medical

View Profile
Address
890 West Pender Street
Vancouver British Columbia V6C 1J9
Canada
Employees -
Website http://www.imaginmedical.com
Updated 07/08/2019
Imagin Medical, Inc. is developing imaging solutions for the early detection of cancer through the use of endoscopes. It focuses on the treatment of bladder cancer through its ultrasensitive imaging technology, which is based upon improved optical designs and advanced light sensors. The company was founded on February 6, 1986 and is headquartered in Vancouver, Canada.